Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32021-05-0427OAAI
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approachATHEROSCLEROSISIF5.72015-10-0119PREAI
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysisJOURNAL OF LIPID RESEARCHIF4.12013-12-0184OAAI
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysisINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22013-10-0116PREAI
Mutations in the ANGPTL3 Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical CharacterizationJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12012-07-01141OAAI
The relationship between metabolic syndrome, its components, and the whole-body atherosclerotic disease burden as measured by computed tomography angiographyATHEROSCLEROSISIF5.72011-04-019PREAI
Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiographyINTERNAL AND EMERGENCY MEDICINEIF3.82011-03-055PREAI
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemiaMETABOLISM-CLINICAL AND EXPERIMENTALIF11.92007-11-0120PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向